The freeze problem
A frozen and thawed vial looks exactly like one that was never frozen. That is what makes cold excursions more dangerous than warm ones — not because the damage is worse, but because nothing about the delivered product signals it. A melted gel pack tells a patient something went wrong. A refrozen one tells them nothing.
Freezing is a discard condition under approved GLP-1 labeling, and USP <659> permits no excursion below 2°C under controlled cold temperature. Winter packout design is therefore two-sided: hold the payload at or above 2°C while still keeping it below 8°C.
Almost all cold chain content, and almost all cold chain marketing, is written about heat. Summer protocols, melt thresholds, how many gel packs for a July lane. The result is an industry that has trained pharmacies to treat refrigerant quantity as a proxy for safety — a heuristic that is directionally right for four months of the year and actively harmful for the rest.
Why adding refrigerant can cause the failure
Water-based gel packs are typically conditioned in a freezer, which means they leave the packing bench at well below 0°C. A gel pack at −18°C placed in direct contact with a vial does not gently hold that vial at 5°C. It pulls the surface it touches toward its own temperature until it warms through.
In a warm-ambient shipment this is usually harmless because the environment is fighting back. In a cold-ambient shipment there is nothing to fight back with, and the same packout that performed well in August can drive a payload below freezing in January. The lane did not change and the packout did not change — only the direction of the temperature gradient did.
“Add another gel pack” is the standard response to a warm arrival. Applied in winter, on a cold lane, it increases freeze risk rather than reducing risk generally. Refrigerant quantity is not a safety dial with one direction — it is one variable in a two-sided design problem.
Conditioning is the variable nobody documents
The temperature a refrigerant starts at matters as much as how much of it you use, and it is the specification most likely to be missing from a pharmacy’s written procedure. The same gel pack behaves differently depending on whether it came out of a freezer at −18°C, a conditioning step that let it equilibrate, or a refrigerator at 5°C.
| Starting state | Behaviour | Appropriate use |
|---|---|---|
| Frozen hard −18°C from freezer |
Long duration, high risk of driving payload below 0°C on contact | High-ambient lanes, with a barrier layer between refrigerant and payload |
| Conditioned held to partial phase change |
Sits near its phase transition; less aggressive initial pull | Most 2–8°C applications |
| Refrigerated 2–8°C from fridge |
Minimal freeze risk, substantially shorter hold | Short cold-ambient lanes |
| Phase-change material engineered transition point |
Holds near a designed temperature rather than near 0°C | Two-sided problems where both bounds are tight |
The reason phase-change materials formulated for 2–8°C exist at all is this problem. A water-based gel pack’s phase transition is at 0°C, which is precisely the boundary you are trying not to cross. A PCM engineered to change phase at, say, 5°C holds near a temperature inside your target band rather than at its edge.
Why the detection asymmetry matters operationally
Consider the two failure modes from the receiving end.
- Heat excursion. Gel packs are liquid and warm. The box feels warm. Patients notice and call. The pharmacy learns about the failure, replaces the shipment, and gets a data point about the lane.
- Freeze excursion. Gel packs are solid, which looks correct. The vial is clear, which looks correct. Nothing prompts a call. The product is administered, and the pharmacy never learns anything.
This asymmetry corrupts your operational picture. A pharmacy that tracks complaints as its quality signal is running a detector that is blind in one direction, which means winter lane performance can degrade for an entire season without generating a single data point. It also means the complaint-free winter is not evidence of a working system.
Some visual signals do exist for solutions — particulates, cloudiness, or protein aggregation may be visible after a freeze-thaw in some formulations — but they are inconsistent and formulation-dependent. Absence of visible change is not evidence the product stayed above freezing.
Designing for the cold side
- Never let refrigerant touch the payload directly. A barrier layer between the two is the single most effective freeze control, and it costs almost nothing.
- Specify conditioning in writing. Starting temperature and conditioning time belong in the packing procedure, not in a technician’s habit.
- Run seasonal profiles, not one profile. A packout validated only against a summer ambient profile is unvalidated for half the year. Chamber testing should include a winter profile.
- Consider reducing refrigerant in deep cold. On a genuinely cold lane the ambient is doing your cooling. The packout’s job shifts toward insulation — keeping the payload from equilibrating with an environment that is too cold.
- Watch the shoulder seasons. Spring and autumn lanes can hit both extremes in one transit: a warm loading dock, a cold overnight line-haul, a warm delivery vehicle. These are the hardest profiles to design for and the least likely to be tested.
Meridian packouts are chamber-tested against both summer-peak and winter ambient profiles, and our packing specifications state refrigerant conditioning explicitly rather than leaving it to the bench. If your current packout was specified against a summer profile only, a winter lane test is the cheapest way to find out what it does in February.
Frequently asked questions
Can you tell if a peptide vial has been frozen?
Often not. A frozen and thawed vial frequently appears identical to one that was never frozen. Some formulations may show particulates or cloudiness after freeze-thaw, but this is inconsistent, and the absence of visible change is not evidence the product stayed above 2°C.
Is freezing worse than overheating for peptides?
Approved GLP-1 labeling treats freezing as a discard condition without qualification, which is a stricter position than the labeled tolerance for elevated temperature after first use. Combined with the detection problem, freeze excursions are reasonably treated as the more dangerous failure mode.
Why would adding more gel packs make things worse?
Gel packs conditioned in a freezer start well below 0°C. On a cold-ambient lane there is no warm environment to offset them, so additional refrigerant increases the chance of pulling the payload below freezing. Refrigerant quantity should be matched to the ambient profile, not increased by default.
What temperature should gel packs be when packed?
It depends on the ambient profile and the packout design, which is why it should be specified in your written procedure rather than left to habit. Hard-frozen refrigerant needs a barrier between it and the payload; conditioned or refrigerated refrigerant carries less freeze risk and less hold time.
Do I need a different packout for winter?
Not necessarily a different container, but you likely need a different refrigerant configuration and conditioning specification. The relevant test is whether your packout has been validated against a winter ambient profile at all — many have not.
What does USP say about the lower bound?
USP <659> defines controlled cold temperature as 2–8°C with excursions permitted between 2°C and 15°C. No excursion below 2°C is permitted, which makes the cold side a defined limit rather than a matter of judgment.
Has your packout been tested against a winter profile?
Most have not. We will run a lane test on your route in the season you are actually worried about, with the chamber data alongside it.
Request a lane testSources
- USP General Chapter <659>, Packaging and Storage Requirements — controlled cold temperature definition.
- Novo Nordisk, GLP-1 receptor agonist storage and stability information.
- USP General Chapter <1079>, Risks and Mitigation Strategies for the Storage and Transportation of Finished Drug Products. USP.org.
- ISTA thermal transport test standards, including paired summer and winter ambient profiles. ISTA.